More Surprises From Trump On Drug Pricing
Donald Trump’s Centers for Medicare and Medicaid Services (CMS) in late January said it would continue Medicare drug price negotiations. Then, in a Super Bowl interview, Trump bemoaned the cost of GLP-1 weight-loss drugs in America compared with other developed nations. Now, the Trump administration has chosen to defend the Medicare drug price reform law in court.
In a filing Feb. 19, the government agreed with the legal arguments used by the Biden administration and by a lower court.
Trump so far is not what Big Pharma hoped.
#ira #medicare #partd #drugpricing #branddrugmakers
